Smooth muscle progenitor cells: A novel target for the treatment of vascular disease?

Muscle

Volumn 2, Issue , 2012, Pages 1391-1400

  Schober, Andreas ^a   Zhe, Zhou ^a   Weber, Christian ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Inst fur Prophylaxe und Epidemiol   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878614253     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381510-1.00107-1     Document Type: Chapter

References (69)

1. Hristov M., Weber C. Ambivalence of progenitor cells in vascular repair and plaque stability. Curr Opin Lipidol 2008, 19:491-497.
2. van Oostrom O., Fledderus J.O., de Kleijn D., Pasterkamp G., Verhaar M.C. Smooth muscle progenitor cells: friend or foe in vascular disease?. Curr Stem Cell Res Ther 2009, 4:131-140.
3. Owens G.K., Kumar M.S., WamhoffB.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84:767-801.
4. Kane N.M., Xiao Q., Baker A.H., Luo Z., Xu Q., Emanueli C. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation). Pharmacol Ther 2011, 129:29-49.
5. Orlandi A., Bennett M. Progenitor cell-derived smooth muscle cells in vascular disease. Biochem Pharmacol 2010, 79:1706-1713.
6. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409.
7. Schober A., Knarren S., Lietz M., Lin E.A., Weber C. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003, 108:2491-2497.
8. Zernecke A., Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res 2010, 86:192-201.
9. Zernecke A., Schober A., Bot I., von Hundelshausen P., Liehn E.A., Mopps B., et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005, 96:784-791.
10. Sahara M., Sata M., Matsuzaki Y., Tanaka K., Morita T., Hirata Y., et al. Comparison of various bone marrow fractions in the ability to participate in vascular remodeling after mechanical injury. Stem Cells 2005, 23:874-878.
11. Iwata H., Manabe I., Fujiu K., Yamamoto T., Takeda N., Eguchi K., et al. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 2010, 122:2048-2057.
12. Kumar A.H., Metharom P., Schmeckpeper J., Weiss S., Martin K., Caplice N.M. Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J 2010, 24:81-92.
13. Subramanian P., Karshovska E., Reinhard P., Megens R.T.A., Zhou Z., Akhtar S., et al. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation. Circ Res 2010, 107:96-105.
14. Yu H., Stoneman V., Clarke M., Figg N., Xin H.B., KotlikoffM., et al. Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler Thromb Vasc Biol 2011, 31:1291-1299.
15. Kashiwakura Y., Katoh Y., Tamayose K., Konishi H., Takaya N., Yuhara S., et al. Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow. Circulation 2003, 107:2078-2081.
16. Inoue T., Sata M., Hikichi Y., Sohma R., Fukuda D., Uchida T., et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 2007, 115:553-561.
17. Schober A., Hoffmann R., Opree N., Knarren S., Iofina E., Hutschenreuter G., et al. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease. Am J Cardiol 2005, 96:1116-1122.
18. Schober A., Weber C. Bone marrow-derived smooth muscle cells are breaking bad in atherogenesis. Arterioscler Thromb Vasc Biol 2011, 31:1258-1259.
19. Sugiyama S., Kugiyama K., Nakamura S., Kataoka K., Aikawa M., Shimizu K., et al. Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis 2006, 187:351-362.
20. Hagensen M.K., Shim J., Falk E., Bentzon J.F. Flanking recipient vasculature, not circulating progenitor cells, contributes to endothelium and smooth muscle in murine allograft vasculopathy. Arterioscler Thromb Vasc Biol 2011, 31:808-813.
21. Tanaka K., Sata M., Hirata Y., Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 2003, 93:783-790.
22. Yu H., Stoneman V., Clarke M., Figg N., Xin H.B., KotlikoffM., et al. Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler Thromb Vasc Biol 2011, 31:1291-1299.
23. Cui Y.Z., Hisha H., Yang G.X., Fan T.X., Jin T., Li Q., et al. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant 2002, 30:843-849.
24. Psaltis P.J., Harbuzariu A., Delacroix S., Holroyd E.W., Simari R.D. Resident vascular progenitor cells - diverse origins, phenotype, and function. J Cardiovasc Transl Res 2011, 4:161-176.
25. Torsney E., Xu Q. Resident vascular progenitor cells. J Mol Cell Cardiol 2011, 50:304-311.
26. Frid M.G., Aldashev A.A., Dempsey E.C., Stenmark K.R. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities. Circ Res 1997, 81:940-952.
27. Sainz J., Al Haj Zen A., Caligiuri G., Demerens C., Urbain D., Lemitre M., et al. Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 2006, 26:281-286.
28. Pasquinelli G., Pacilli A., Alviano F., Foroni L., Ricci F., Valente S., et al. Multidistrict human mesenchymal vascular cells: pluripotency and stemness characteristics. Cytotherapy 2010, 12:275-287.
29. Bearzi C., Leri A., Lo Monaco F., Rota M., Gonzalez A., Hosoda T., et al. Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci USA 2009, 106:15885-15890.
30. Hu Y., Zhang Z., Torsney E., Afzal A.R., Davison F., Metzler B., et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004, 113:1258-1265.
31. + smooth muscle progenitor cells. Proc Natl Acad Sci USA 2008, 105:9349-9354.
32. + multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS One 2011, 6:e20540.
33. Linton M.F., Atkinson J.B., Fazio S. Prevention of atherosclerosis in apolipoprotein e-deficient mice by bone marrow transplantation. Science 1995, 267:1034-1037.
34. Bentzon J.F., Weile C., Sondergaard C.S., Hindkjaer J., Kassem M., Falk E. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in apoe knockout mice. Arterioscle Thromb Vasc Biol 2006, 26:2696-2702.
35. Falk E., Schwartz S.M., Galis Z.S., Rosenfeld M.E. Putative murine models of plaque rupture. Arterioscler Thromb Vasc Biol 2007, 27:969-972.
36. Jackson C.L., Bennett M.R., Biessen E.A., Johnson J.L., Krams R. Assessment of unstable atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007, 27:714-720.
37. Bentzon J.F., Sondergaard C.S., Kassem M., Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007, 116:2053-2061.
38. Caplice N.M., Bunch T.J., Stalboerger P.G., Wang S., Simper D., Miller D.V., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 2003, 100:4754-4759.
39. Zoll J., Fontaine V., Gourdy P., Barateau V., Vilar J., Leroyer A., et al. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 2008, 77:471-480.
40. Campagnolo P., Wong M.M., Xu Q. Progenitor cells in arteriosclerosis: good or bad guys?. Antioxid Redox Signal 2011, 15:1013-1027.
41. Rahmani M., Cruz R.P., Granville D.J., McManus B.M. Allograft vasculopathy versus atherosclerosis. Circ Res 2006, 99:801-815.
42. Religa P., Bojakowski K., Bojakowska M., Gaciong Z., Thyberg J., Hedin U. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Cardiovasc Res 2005, 65:535-545.
43. Saiura A., Sata M., Hirata Y., Nagai R., Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001, 7:382-383.
44. Hillebrands J.L., Klatter F.A., van den Hurk B.M., Popa E.R., Nieuwenhuis P., Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001, 107:1411-1422.
45. Hu Y., Davison F., Ludewig B., Erdel M., Mayr M., Url M., et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106:1834-1839.
46. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., et al. Chimerism of the transplanted heart. N Engl J Med 2002, 346:5-15.
47. Daniel J.M., Sedding D.G. Circulating smooth muscle progenitor cells in arterial remodeling. J Mol Cell Cardiol 2011, 50:273-279.
48. Han C.I., Campbell G.R., Campbell J.H. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2001, 38:113-119.
49. Tanaka K., Sata M., Natori T., Kim-Kaneyama J.R., Nose K., Shibanuma M., et al. Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice. FASEB J 2008, 22:428-436.
50. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008, 28:1950-1959.
51. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 184:1101-1109.
52. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., et al. G-csf induces stem cell mobilization by decreasing bone marrow sdf-1 and up-regulating cxcr4. Nat Immunol 2002, 3:687-694.
53. Shiba Y., Takahashi M., Yoshioka T., Yajima N., Morimoto H., Izawa A., et al. M-csf accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system. Arterioscler Thromb Vasc Biol 2007, 27:283-289.
54. Yokoi H., Yamada H., Tsubakimoto Y., Takata H., Kawahito H., Kishida S., et al. Bone marrow at1 augments neointima formation by promoting mobilization of smooth muscle progenitors via platelet-derived SDF-1. Arterioscler Thromb Vasc Biol 2009, 30:60-67.
55. Karshovska E., Zagorac D., Zernecke A., Weber C., Schober A. A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury. J Thromb Haemost 2008, 6:1812-1815.
56. Yoshida K., Nishida W., Hayashi K., Ohkawa Y., Ogawa A., Aoki J., et al. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 2003, 108:1746-1752.
57. Karshovska E., Zernecke A., Sevilmis G., Millet A., Hristov M., Cohen C.D., et al. Expression of hif-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:2540-2547.
58. NemenoffR.A., Simpson P.A., Furgeson S.B., Kaplan-Albuquerque N., Crossno J., Garl P.J., et al. Targeted deletion of pten in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ Res 2008, 102:1036-1045.
59. NemenoffR.A., Horita H., Ostriker A.C., Furgeson S.B., Simpson P.A., VanPutten V., et al. SDF-1alpha induction in mature smooth muscle cells by inactivation of pten is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler Thromb Vasc Biol 2011, 31:1300-1308.
60. Ikesue M., Matsui Y., Ohta D., Danzaki K., Ito K., Kanayama M., et al. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization. Arterioscler Thromb Vasc Biol 2011, 31:1066-1074.
61. Yang D., Koupenova M., McCrann D.J., Kopeikina K.J., Kagan H.M., Schreiber B.M., et al. The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci USA 2008, 105:792-796.
62. Zhang L.N., Wilson D.W., da Cunha V., Sullivan M.E., Vergona R., Rutledge J.C., et al. Endothelial no synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol 2006, 26:765-772.
63. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008, 8:802-815.
64. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., et al. Hmg-coa reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest 2001, 108:391-397.
65. Kusuyama T., Omura T., Nishiya D., Enomoto S., Matsumoto R., Murata T., et al. The effects of hmg-coa reductase inhibitor on vascular progenitor cells. J Pharmacol Sci 2006, 101:344-349.
66. Satoh K., Fukumoto Y., Nakano M., Sugimura K., Nawata J., Demachi J., et al. Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1. Cardiovasc Res 2009, 81:226-234.
67. Pendyala L.K., Yin X., Li J., Chen J.P., Chronos N., Hou D. The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC Cardiovasc Interv 2009, 2:1169-1177.
68. Zernecke A., Bot I., Djalali-Talab Y., Shagdarsuren E., Bidzhekov K., Meiler S., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008, 102:209-217.
69. Mehta N.N., Li M., William D., Khera A.V., Derohannessian S., Qu L., et al. The novel atherosclerosis locus at 10q11 regulates plasma cxcl12 levels. Eur Heart J 2011, 32:963-971.